The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Quantitative assessment of BRAF V600 mutant cell-free tumor DNA from plasma as a diagnostic and therapeutic biomarker in pts with BRAF V600 mutant melanoma.
 
Max Schreuer
No Relationships to Disclose
 
Geert Meersseman
Employment - Biocartis
 
Yanina Jansen
No Relationships to Disclose
 
Teofila Seremet
No Relationships to Disclose
 
Ines Chevolet
No Relationships to Disclose
 
Ambre Bott
No Relationships to Disclose
 
Sofie Wilgenhof
No Relationships to Disclose
 
Geert Maertens
Employment - Biocartis
 
Bart Neyns
Honoraria - Bristol-Myers Squibb; Cryostorage; GlaxoSmithKline; Merck Sharp & Dohme; Roche Pharma AG
Consulting or Advisory Role - Bristol-Myers Squibb; Cryostorage; GlaxoSmithKline; Merck Sharp & Dohme; Pfizer; Roche Pharma AG
Research Funding - GlaxoSmithKline; Merck Sharp & Dohme; Pfizer; Roche Pharma AG